These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 18718610)
1. Re: The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis? J. Feliciano, E. Teper, M. Ferrandino, R. J. Macchia, W. Blank, I. Grunberger and I. Colon J Urol 2008; 179: 952-955. Ng CF; Chan SY J Urol; 2008 Oct; 180(4):1570-1; author reply 1571. PubMed ID: 18718610 [No Abstract] [Full Text] [Related]
2. The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis? Feliciano J; Teper E; Ferrandino M; Macchia RJ; Blank W; Grunberger I; Colon I J Urol; 2008 Mar; 179(3):952-5; discussion 955. PubMed ID: 18207185 [TBL] [Abstract][Full Text] [Related]
3. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy. Young JL; Liss MA; Szabo RJ Urology; 2009 Aug; 74(2):332-8. PubMed ID: 19464041 [TBL] [Abstract][Full Text] [Related]
4. Editorial comment. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy. Hernandez-Graulau JM Urology; 2009 Aug; 74(2):338-9; author reply 339. PubMed ID: 19646618 [No Abstract] [Full Text] [Related]
5. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy. Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030 [TBL] [Abstract][Full Text] [Related]
6. Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment. Zaytoun OM; Vargo EH; Rajan R; Berglund R; Gordon S; Jones JS Urology; 2011 May; 77(5):1035-41. PubMed ID: 21420152 [TBL] [Abstract][Full Text] [Related]
7. Extended-spectrum beta-lactamase gram-negative sepsis following prostate biopsy: implications for use of fluoroquinolone prophylaxis. Cannon GM; Smaldone MC; Paterson DL Can J Urol; 2007 Aug; 14(4):3653-5. PubMed ID: 17784990 [TBL] [Abstract][Full Text] [Related]
8. Antibiotic prophylaxis with intravenous ceftriaxone and fluoroquinolone reduces infectious complications after transrectal ultrasound-guided prostatic biopsy. Lee C; You D; Jeong IG; Hong JH; Choo MS; Ahn H; Ahn TY; Kim CS Korean J Urol; 2015 Jun; 56(6):466-72. PubMed ID: 26078845 [TBL] [Abstract][Full Text] [Related]
9. Fluoroquinolone prophylaxis in patients with neutropenia. Zinner SH Clin Infect Dis; 2005 Apr; 40(8):1094-5. PubMed ID: 15791506 [No Abstract] [Full Text] [Related]
10. [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia]. Qin TJ; Mi YC; Feng SZ; Li DP; Wei JL; Yang DL; Han MZ; Wang JX; Bian SG Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1389-93. PubMed ID: 17785058 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis. Adibi M; Pearle MS; Lotan Y BJU Int; 2012 Jul; 110(2 Pt 2):E86-91. PubMed ID: 22115356 [TBL] [Abstract][Full Text] [Related]
19. Is the current antibiotic prophylaxis policy in transrectal prostate biopsy still safe? Thompson PM; Philpott-Howard J; Wang W BJU Int; 2009 Jul; 104(2):271-2. PubMed ID: 19594518 [No Abstract] [Full Text] [Related]
20. Rectal swab culture-directed antimicrobial prophylaxis for prostate biopsy and risk of postprocedure infection: a cohort study. Dai J; Leone A; Mermel L; Hwang K; Pareek G; Schiff S; Golijanin D; Renzulli JF Urology; 2015 Jan; 85(1):8-14. PubMed ID: 25458193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]